510(k) Report

510(k) · Cleared

Cleared

ABL80 FLEX and ABL80 FLEX CO-OX

K151639510(k) TraditionalCleared Dec 7, 2015172-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sendx Medical, Inc. · CGA Glucose Oxidase, Glucose

Cleared on Dec 7, 2015 as substantially equivalent to K043218 (Radiometer Medical Aps, 2005) after a 172-day review. Its family tree reaches back 6 generations to 1986.

Decided
Dec 7, 2015
Review
172 days
Class
Class II
Product code
CGA
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K861087 (1986). 17 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK861087 Avl Model 983 Electrolyte AnalyzerAvl Scientific Corp. · 1986
  2. 5 generations backK961458 Avl 9180 Electrolyte AnalyzerAvl Scientific Corp. · 1996 · Recalled
  3. 4 generations backK972673 Avl 9181 Electrolyte AnalyzerAvl Scientific Corp. · 1997 · Recalled
  4. 3 generations backK992859 ABL700 Series Analyzer with Autocheck ModuleRadiometer America, Inc. · 2000 · Recalled
  5. 2 generations backK041874 ABL800 FlexRadiometer Medical Aps · 2004 · Recalled
  6. 1 generation backK043218 ABL800 Flex with Flexq Module, Model ABL8XXRadiometer Medical Aps · 2005 · Recalled
  7. This deviceK151639 ABL80 FLEX and ABL80 FLEX CO-OXSendx Medical, Inc. · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K861087Avl Model 983 Electrolyte AnalyzerAvl Scientific Corp.1986—
−5K961458Avl 9180 Electrolyte AnalyzerAvl Scientific Corp.19961
−4K972673Avl 9181 Electrolyte AnalyzerAvl Scientific Corp.19977
−3K992859ABL700 Series Analyzer with Autocheck ModuleRadiometer America, Inc.20004
−2K041874ABL800 FlexRadiometer Medical Aps200422
−1K043218ABL800 Flex with Flexq Module, Model ABL8XXRadiometer Medical Aps20053
0 (this device)K151639ABL80 FLEX and ABL80 FLEX CO-OXSendx Medical, Inc.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
198710
199210
199510
199630
199710
199820
200010
FIG. 1 — Lineage of K151639, 1986–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CGA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CGA device

  1. #1 K252488 ABL90 FLEX PLUS Systemscore 12.8 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K043218ABL800 Flex with Flexq Module, Model ABL8XX
Summary page 6
…ended for use in a laboratory environment, near patient or point-of-care setting. For in vitro diagnostic use. 4. Predicate device: ABL800 FLEX analyzer (K043218) Substantial Equivalence The modified ABL80 FLEX and ABL80 FLEX CO-OX analyzers are substantially equivalent in Intended Use, fun…
Radiometer Medical Aps20053

Also cleared against K043218: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 29 years and passes through 4 companies; a new generation was cleared every 4.7 years on median.
  • 10 of the 17 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K043218.

How does its category compare?

All CGA devices

CGA Glucose Oxidase, Glucose: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · CGA

2in 2024

2007: 72008: 62009: 102010: 82011: 92012: 102013: 32014: 52015: 42016: 42017: 22018: 22019: 22020: 22021: 12022: 12023: 42024: 22026 (partial year): 1
2007high 10 (2009) · low 0 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CGA

249in 2023

2007: 122 days median2008: 56 days median2009: 155 days median2010: 122 days median2011: 217 days median2012: 123 days median2013: 441 days median2014: 265 days median2015: 150 days median2016: 157 days median2023: 249 days median
2007high 441 (2013) · low 56 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CGA

3in 2023

2007: 22008: 22009: 42010: 62011: 32013: 32014: 22015: 6, 2 Class I2016: 22019: 12023: 3
2007high 6 (2010) · low 0 (2012)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · CGA

59in 2025

2007: 292008: 372009: 752010: 1722011: 4232012: 2332013: 1722014: 1222015: 1552016: 362017: 922018: 692019: 1162020: 682021: 482022: 2722023: 1,1412024: 2662025: 59
2007high 1,141 (2023) · low 29 (2007)2025

MAUDE reports naming product code CGA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20077122229
2008656237
200910155475
201081226172
201192173423
2012101230233
201334413172
201452652122
201541506 (2)155
20164157236
20172—092
20182—069
20192—1116
20202—068
20211—048
20221—0272
2023424931,141
20242—0266
20250—059
20261—0—

What is it indicated for?

The ABL80 FLEX analyzer is a portable, automated analyzer that measures glucose, in whole blood. The ABL80 FLEX analyzer system is intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a laboratory environment, near patient or point-of-care setting.

For in vitro diagnostic use.

The ABL80 FLEX CO-OX analyzer is a portable, automated analyzer that measures glucose, in whole blood. The ABL80 FLEX CO-OX analyzer system is intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a laboratory environment, near patient or point-of-care setting.

For in vitro diagnostic use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K151639: ABL80 FLEX and ABL80 FLEX CO-OX.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K151639

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026